VoxNeuro receives Health Canada Class II Medical Device designation

Collaborative innovation provides patients with a new CHAMP

HAMILTON, Ontario — VoxNeuro has received Health Canada Class II Medical Device designation for its proprietary Cognitive Health Assessment Management Platform™ (CHAMP). VoxNeuro will begin rolling out the software as a medical device across its Canadian Test Centers. This news comes hot on the heels of VoxNeuro’s FDA registration for the distribution of CHAMP as a Class II Exempt Medical Device in the US market this past May

Read More
Greening Marketing